Dear Sir,

The first wave of the coronavirus (COVID-19) pandemic was considered to peak in the United Kingdom on 8th April 2020. NHS England guidance advised on the 29th April that within six weeks, all urgent surgery should be provided at pre-pandemic capacity.[@bib0001]

The plastic surgery service at Oxford University Hospitals made significant changes to the structure and delivery of services at the start of the pandemic.[@bib0002] Hand trauma referrals have been triaged by consultants via telemedicine, in-house patients reviewed by the most senior clinician available and patients requiring surgical intervention allocated directly to a theatre list for a 'see and treat' approach. All elective surgeries were paused, with cancer services continuing on 'clean' sites, using stringent protocols involving pre-operative isolation and swab testing. As of the 25th June, Oxfordshire had 2125 confirmed cases of COVID-19 in a population of 691,000.[@bib0003]

There have been limited reports on the outcomes of plastic surgery patients operated on during the pandemic. The COVIDSurg collaborative published its first cohort of 1128 patients, diagnosed with COVID-19 in the perioperative period, reporting a 30-day mortality of 23.8% and 51.2% suffering pulmonary complications.[@bib0004] However, only three patients were operated on by plastic surgery services.

A retrospective service evaluation in a single tertiary trauma centre reviewed all patients operated on by our plastic surgery department between the 9th March (two weeks prior to lockdown) and 28th April, covering the peak of the outbreak. The intention was to advise our unit on the safe restarting of services, identifying the potential risk of contracting the virus when undergoing operative intervention. During this period, 349 patients (200 trauma; 149 elective) underwent 370 procedures, across five sites (four maintained as 'clean'). Cases were predominantly under local anaesethetic (LA) or wide awake local anaesthetic no tourniquet (WALANT) technique (62.7%, 232/370). The remainder were under general anaesthetic (GA) (36.5%, 135/370), or regional anaesthesia (RA) (0.8%, 3/370).

Of the 349 patients, 23 underwent COVID-19 PCR testing within 30 days of a procedure; 16 for routine admission testing or pre-operative screening and seven for symptoms or radiology suggestive of COVID-19. None of the patients had suspected or confirmed COVID-19 at the time of operation; one asymptomatic patient was subsequently found to be positive at the time of theatre. Three patients had positive swabs post-operatively; two whilst an inpatient within 14 days of their operation and one on readmission 10 days after discharge. The former two inpatients died from COVID-19 within 30 days of a major GA procedure; both were over 85 years with multiple co-morbidities.

We reviewed records and contacted patients by telephone at least 14 days post- operatively to assess if they had suffered symptoms, required assessment or admission for COVID-19. 144 patients answered, with a response rate of 44.7%. Patients were not contacted if they were under the lead care of another speciality (*n* = 17), lacked capacity (*n* = 5), were admitted (*n* = 1) or deceased at the time of contact (*n* = 4). All other patients could not be contacted, despite multiple attempts, or declined to respond.

Telephone calls identified one paediatric patient who had suspected symptoms three days following an elective GA procedure but did not undergo testing or require medical attention. Review of records identified two further patients who had died within 30 days of a LA day case procedure. One presented to another hospital with respiratory symptoms, but had a negative COVID-19 PCR test three days post-procedure. The other did not present to hospital or undergo testing but suspected COVID-19 was recorded as a cause of death. Both were elderly with a Clinical Frailty Scale score over six.

To our knowledge, 2.6% (9/349) patients developed possible coronavirus symptoms or abnormal radiology following procedures in our department during the COVID-19 pandemic with 0.9% (3/349) having a positive test (two patients with symptoms were not tested). Those with positive tests all underwent GA procedures and were inpatients for over ten days. Overall 30-day mortality of the patient group was 1.1% (4/349), with two of these deaths confirmed as COVID-19 related and one suspected.

Following significant departmental discussion and government guidance, electives have cautiously restarted utilising clear protocols, initially focussing on LA procedures. Elective patients must isolate for 14 days and have negative PCR testing 72 h before their procedure. We will continue to monitor if patients develop symptoms of COVID-19 post-operatively

Our study provides some evidence to suggest that plastic surgery procedures, especially under LA as a day case, carry limited risk of patients developing symptoms of COVID-19, as long as stringent guidelines are followed. Rarely patients may contract COVID-19, and if vulnerable, are likely to have a high mortality rate from the infection, similar to frail elderly patients who develop COVID-19 infection without undergoing surgery[@bib0005]. Therefore, we advise caution in elderly patients and those with underlying health conditions.
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